Paper Information

Journal:   ARCHIVES OF PEDIATRIC INFECTIOUS DISEASES   JANUARY 2015 , Volume 3 , Number 1; Page(s) 1 To 3.
 
Paper: 

DRUG-RESISTANT TUBERCULOSIS AND GROUP 5 ANTI-TUBERCULOSIS DRUGS

 
 
Author(s):  SHOKOUHI SHERVIN*, ALAVI DARAZAM ILAD
 
* DEPARTMENT OF INFECTIOUS DISEASES AND TROPICAL MEDICINE, SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES, TEHRAN, IR IRAN
 
Abstract: 

The first case of multi-drug resistant (MDR) tuberculosis (TB) was reported in 1993 in New York City and the next year the World Health Organization (WHO) declared a global TB emergency (1, 2). Two decades later, in 2010, WHO estimated that 650,000 cases of MDR TB have been reported worldwide (3). This was not the end of the explosive process, and estimation of WHO for 2015 was more than 1.3 million people in 27 countries (2). Unfortunately, the world confronted more complications during the 2000s. Reports of extensively drug-resistant TB (XDR) and totally drug-resistant TB (TDR) were published between 2003 and 2006 (2, 4).

 
Keyword(s): MULTI-DRUG RESISTANT TUBERCULOSIS, EXTENSIVELY DRUG-RESISTANT TUBERCULOSIS
 
References: 
  • ندارد
 
  pdf-File tarjomyar Yearly Visit 84
 
Latest on Blog
Enter SID Blog